LI
CALA

Leap Investments’s Calithera Biosciences, Inc CALA Stock Holding History

Leap Investments’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$57K Buy
+542
New +$64.4K 0.04% 380

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Leap Investments's CALA Position: Q2 2020 in Review

Leap Investments opened a new position in Calithera Biosciences, Inc (CALA) in Q2 2020: 542 shares worth $57K. The stake represents 0.04% of the portfolio and ranks #380 among its holdings.

110 funds tracked by Wall St. Rank hold CALA as of Q2 2020.

  • Leap Investments held 542 shares of Calithera Biosciences, Inc worth $57K as of Q2 2020.
  • Calithera Biosciences, Inc was a new Leap Investments position in Q2 2020.
  • Calithera Biosciences, Inc made up 0.04% of Leap Investments's portfolio in Q2 2020, its #380 holding.
  • 110 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.